type-2-diabetes

Documents about type-2-diabetes

• Lifestyle Intervention in a General Population for Prevention of Ischaemic Heart Disease#28470ClinicalTrials.gov
• Associations of Combined Genetic and Lifestyle Risks With Incident Type 2 Diabetes in the UK Biobank.#122778NCBI PubMed Central
• Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions#136185ClinicalTrials.gov
• Are Audiovisual Materials Superior to Printed Materials in Improving Awareness Among Type 2 Diabetic Patients?#146345ClinicalTrials.gov
• SLEEVEDIAB To Explore the Early and Late Metabolic Effects of Sleeve Gastrectomy in Obese Patients#148695ClinicalTrials.gov
• Analysis of mortality risk and influencing factors in female patients with young-onset type 2 diabetes.#152320NCBI PubMed Central
• Effect of Saxagliptin on EPCs as a Cellular Biomarker for Evaluating Endothelial Dysfunction in Early T2DM Patients#152382ClinicalTrials.gov
• PräVaNet - Structured, Intersectoral, Multiprofessional, Digitized Program to Optimize Cardiovascular Prevention#152549ClinicalTrials.gov
• Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)#152614ClinicalTrials.gov
• Dual task performance in adults with type 2 diabetes mellitus: A systematic review with meta-analysis.#154234NCBI PubMed Central
• Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition#154894ClinicalTrials.gov
• "Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan."#160273ClinicalTrials.gov
• Improving the Diabetic Health of Black Men: MANUP Feasibility Trial#184748ClinicalTrials.gov
• Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance#184801ClinicalTrials.gov
• HNF1A and A1CF coordinate a beta cell transcription-splicing axis that is disrupted in type 2 diabetes#190589Spiral
• Food-Effect Bioavailability Study of FDC(Gemigliptin/Metformin HCl Sustained Release) 50/1000mg(25/500mg x 2tablets)#195523ClinicalTrials.gov
• PANDIA IRIS: Patients With Diabetes and Kidney Failure, an Interdisciplinary Medication Adherence Support Program#126047ClinicalTrials.gov
• Deteksi Dini Diabetes Mellitus Tipe 2 Pada Usia Dewasa Muda Menggunakan Algoritma Decision Tree - C4.5#194648Jutisi : Jurnal Ilmiah Teknik Informatika dan Sistem Informasi
• Hepatic and abdominal adiposity in type 2 diabetes as assessed with machine learning on computed tomography scans.#9094NCBI PubMed Central
• Sofrito and Fruit Consumption Associated with Lower Risk of Type 2 Diabetes in an Urban Latin American Cohort.#9256NCBI PubMed Central
• SGLT2 inhibitor use in type 2 diabetes in England: a population-based cohort study of uptake of NICE guidance#10156bioRxiv / medRxiv
• Clinical Trial to Evaluate the Efficacy and Safety of DA-5218 in Patients With Type 2 Diabetes#18558ClinicalTrials.gov
• Does Vildagliptin Affect Portal Vein Pressure In Patients With Type 2 Diabetes Mellitus? A Cross Sectional Study#28508ClinicalTrials.gov
• Variation of Genes Controlling Carbohydrate and Lipid Metabolism#28542ClinicalTrials.gov
• Refinement and Adaption of Reinforcement Learning to Personalize Behavioral Messaging for Healthy Habits#123630ClinicalTrials.gov
• Observational Study to Evaluate the Efficacy and Safety of Suganon Tab. or Sugamet XR Tab.#126078ClinicalTrials.gov
• Comparative Bioavailability Study of Metformin/Sitagliptin 850 mg/50 mg Tablets in Healthy Male and Female Volunteers#140963ClinicalTrials.gov
• An ancestry-enriched PIEZO1 missense variant biases HbA1c-based diagnosis of prediabetes and type 2 diabetes in South Asians#141242bioRxiv / medRxiv
• Cell-specific DNA methylation in human alpha and beta cells regulates gene expression in type 2 diabetes.#143274NCBI PubMed Central
• Integrated cortical-cognitive signatures identified by machine learning enable early detection of MCI in type 2 diabetes.#143399NCBI PubMed Central
• The Influence of Polypharmacy on Type 2 Diabetes Adverse Cardiovascular Outcomes in a Rural Cohort#152053Unpaywall
• Beyond prescriptions: an analysis of patient journey, self-management adherence, and unmet needs in type 2 diabetes.#162223NCBI PubMed Central
• Rising type 2 diabetes mellitus-related mortality among young adults in the United States: a nationwide analysis.#165913NCBI PubMed Central
• Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors#172489ClinicalTrials.gov
• Determination of Safety,Tolerability,Pharmacokinetics,Food Effect& Pharmacodynamics of Single & Multiple Doses of P11187#180289ClinicalTrials.gov
• Gut-Brain-axis: Targets for Improvement of Cognition in the Elderly#181677ClinicalTrials.gov
• Risk of Bladder Cancer in Type 2 Diabetes Patients With Pioglitazone Therapy "PROBE"#184813ClinicalTrials.gov
• Cost-Effectiveness of Primary Prevention of Stroke in Type 2 Diabetes in the United States: A Microsimulation Analysis.#193624NCBI PubMed Central
• The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin#121316ClinicalTrials.gov
• Adult persons with type 2 diabetes and family engagement in diabetes self-management education and support: what works, for whom, under what circumstances and how? - a realist review protocol.#156797NCBI PubMed Central
• Clinical Potential of GIP in Type 2 Diabetes and Obesity.#178991Apollo
• Application of diffusion tensor imaging analysis along perivascular spaces in evaluating glymphatic system function in type 2 diabetes mellitus.#1300NCBI PubMed Central
• Chronic care management in primary care for patients with type 2 diabetes mellitus in Amazonas.#15202NCBI PubMed Central
• The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN)#67785ClinicalTrials.gov
• La Profilée and the Structural Law of Biological Persistence: Retroactive Structural Analysis of Cancer, Type 2 Diabetes, Sepsis, Coral Bleaching, and Aging#81131PhilArchive
• Enhancing the Efficacy and Tolerability of Metformin by add-on Polyherbal Formulation: a Gut Microbiome Study#121297ClinicalTrials.gov
• Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie#121300ClinicalTrials.gov
• Assessment of Dapagliflozin Effect on Diabetic Endothelial Dysfunction of Brachial Artery#125960ClinicalTrials.gov
• Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure#127722ClinicalTrials.gov
• Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone#146388ClinicalTrials.gov